Global and United States Psoriasis Drugs Market Size, Status and Forecast 2021-2027

Publisher Name :
Date: 26-Aug-2021
No. of pages: 95
Inquire Before Buying

Global Psoriasis Drugs Scope and Market Size

Psoriasis Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Psoriasis Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

- Tumor Necrosis Factor Inhibitor

- Interleukin Inhibitors

- Others

Segment by Application

- Topicals

- Systemic

- Biologics

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- AbbVie

- Amgen

- Johnson & Johnson

- Novartis

- Eli Lilly & Company

- AstraZeneca

- Celgene Corporation

- UCB

- Merck

Global and United States Psoriasis Drugs Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Psoriasis Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Tumor Necrosis Factor Inhibitor
1.2.3 Interleukin Inhibitors
1.2.4 Others
1.3 Market by Application
1.3.1 Global Psoriasis Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Topicals
1.3.3 Systemic
1.3.4 Biologics
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Psoriasis Drugs Market Perspective (2016-2027)
2.2 Psoriasis Drugs Growth Trends by Regions
2.2.1 Psoriasis Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Psoriasis Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Psoriasis Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Psoriasis Drugs Industry Dynamic
2.3.1 Psoriasis Drugs Market Trends
2.3.2 Psoriasis Drugs Market Drivers
2.3.3 Psoriasis Drugs Market Challenges
2.3.4 Psoriasis Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Psoriasis Drugs Players by Revenue
3.1.1 Global Top Psoriasis Drugs Players by Revenue (2016-2021)
3.1.2 Global Psoriasis Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Psoriasis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Psoriasis Drugs Revenue
3.4 Global Psoriasis Drugs Market Concentration Ratio
3.4.1 Global Psoriasis Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Psoriasis Drugs Revenue in 2020
3.5 Psoriasis Drugs Key Players Head office and Area Served
3.6 Key Players Psoriasis Drugs Product Solution and Service
3.7 Date of Enter into Psoriasis Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Psoriasis Drugs Breakdown Data by Type
4.1 Global Psoriasis Drugs Historic Market Size by Type (2016-2021)
4.2 Global Psoriasis Drugs Forecasted Market Size by Type (2022-2027)
5 Psoriasis Drugs Breakdown Data by Application
5.1 Global Psoriasis Drugs Historic Market Size by Application (2016-2021)
5.2 Global Psoriasis Drugs Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Psoriasis Drugs Market Size (2016-2027)
6.2 North America Psoriasis Drugs Market Size by Type
6.2.1 North America Psoriasis Drugs Market Size by Type (2016-2021)
6.2.2 North America Psoriasis Drugs Market Size by Type (2022-2027)
6.2.3 North America Psoriasis Drugs Market Size by Type (2016-2027)
6.3 North America Psoriasis Drugs Market Size by Application
6.3.1 North America Psoriasis Drugs Market Size by Application (2016-2021)
6.3.2 North America Psoriasis Drugs Market Size by Application (2022-2027)
6.3.3 North America Psoriasis Drugs Market Size by Application (2016-2027)
6.4 North America Psoriasis Drugs Market Size by Country
6.4.1 North America Psoriasis Drugs Market Size by Country (2016-2021)
6.4.2 North America Psoriasis Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Psoriasis Drugs Market Size (2016-2027)
7.2 Europe Psoriasis Drugs Market Size by Type
7.2.1 Europe Psoriasis Drugs Market Size by Type (2016-2021)
7.2.2 Europe Psoriasis Drugs Market Size by Type (2022-2027)
7.2.3 Europe Psoriasis Drugs Market Size by Type (2016-2027)
7.3 Europe Psoriasis Drugs Market Size by Application
7.3.1 Europe Psoriasis Drugs Market Size by Application (2016-2021)
7.3.2 Europe Psoriasis Drugs Market Size by Application (2022-2027)
7.3.3 Europe Psoriasis Drugs Market Size by Application (2016-2027)
7.4 Europe Psoriasis Drugs Market Size by Country
7.4.1 Europe Psoriasis Drugs Market Size by Country (2016-2021)
7.4.2 Europe Psoriasis Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Psoriasis Drugs Market Size (2016-2027)
8.2 Asia-Pacific Psoriasis Drugs Market Size by Type
8.2.1 Asia-Pacific Psoriasis Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Psoriasis Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Psoriasis Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Psoriasis Drugs Market Size by Application
8.3.1 Asia-Pacific Psoriasis Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Psoriasis Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Psoriasis Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Psoriasis Drugs Market Size by Region
8.4.1 Asia-Pacific Psoriasis Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Psoriasis Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Psoriasis Drugs Market Size (2016-2027)
9.2 Latin America Psoriasis Drugs Market Size by Type
9.2.1 Latin America Psoriasis Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Psoriasis Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Psoriasis Drugs Market Size by Type (2016-2027)
9.3 Latin America Psoriasis Drugs Market Size by Application
9.3.1 Latin America Psoriasis Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Psoriasis Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Psoriasis Drugs Market Size by Application (2016-2027)
9.4 Latin America Psoriasis Drugs Market Size by Country
9.4.1 Latin America Psoriasis Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Psoriasis Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Psoriasis Drugs Market Size (2016-2027)
10.2 Middle East & Africa Psoriasis Drugs Market Size by Type
10.2.1 Middle East & Africa Psoriasis Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Psoriasis Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Psoriasis Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Psoriasis Drugs Market Size by Application
10.3.1 Middle East & Africa Psoriasis Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Psoriasis Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Psoriasis Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Psoriasis Drugs Market Size by Country
10.4.1 Middle East & Africa Psoriasis Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Psoriasis Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Psoriasis Drugs Introduction
11.1.4 AbbVie Revenue in Psoriasis Drugs Business (2016-2021)
11.1.5 AbbVie Recent Development
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Amgen Business Overview
11.2.3 Amgen Psoriasis Drugs Introduction
11.2.4 Amgen Revenue in Psoriasis Drugs Business (2016-2021)
11.2.5 Amgen Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Psoriasis Drugs Introduction
11.3.4 Johnson & Johnson Revenue in Psoriasis Drugs Business (2016-2021)
11.3.5 Johnson & Johnson Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Psoriasis Drugs Introduction
11.4.4 Novartis Revenue in Psoriasis Drugs Business (2016-2021)
11.4.5 Novartis Recent Development
11.5 Eli Lilly & Company
11.5.1 Eli Lilly & Company Company Details
11.5.2 Eli Lilly & Company Business Overview
11.5.3 Eli Lilly & Company Psoriasis Drugs Introduction
11.5.4 Eli Lilly & Company Revenue in Psoriasis Drugs Business (2016-2021)
11.5.5 Eli Lilly & Company Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Psoriasis Drugs Introduction
11.6.4 AstraZeneca Revenue in Psoriasis Drugs Business (2016-2021)
11.6.5 AstraZeneca Recent Development
11.7 Celgene Corporation
11.7.1 Celgene Corporation Company Details
11.7.2 Celgene Corporation Business Overview
11.7.3 Celgene Corporation Psoriasis Drugs Introduction
11.7.4 Celgene Corporation Revenue in Psoriasis Drugs Business (2016-2021)
11.7.5 Celgene Corporation Recent Development
11.8 UCB
11.8.1 UCB Company Details
11.8.2 UCB Business Overview
11.8.3 UCB Psoriasis Drugs Introduction
11.8.4 UCB Revenue in Psoriasis Drugs Business (2016-2021)
11.8.5 UCB Recent Development
11.9 Merck
11.9.1 Merck Company Details
11.9.2 Merck Business Overview
11.9.3 Merck Psoriasis Drugs Introduction
11.9.4 Merck Revenue in Psoriasis Drugs Business (2016-2021)
11.9.5 Merck Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Psoriasis Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Tumor Necrosis Factor Inhibitor
Table 3. Key Players of Interleukin Inhibitors
Table 4. Key Players of Others
Table 5. Global Psoriasis Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Psoriasis Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Psoriasis Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Psoriasis Drugs Market Share by Regions (2016-2021)
Table 9. Global Psoriasis Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Psoriasis Drugs Market Share by Regions (2022-2027)
Table 11. Psoriasis Drugs Market Trends
Table 12. Psoriasis Drugs Market Drivers
Table 13. Psoriasis Drugs Market Challenges
Table 14. Psoriasis Drugs Market Restraints
Table 15. Global Psoriasis Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Psoriasis Drugs Market Share by Players (2016-2021)
Table 17. Global Top Psoriasis Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Psoriasis Drugs as of 2020)
Table 18. Ranking of Global Top Psoriasis Drugs Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Psoriasis Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Psoriasis Drugs Product Solution and Service
Table 22. Date of Enter into Psoriasis Drugs Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Psoriasis Drugs Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Psoriasis Drugs Revenue Market Share by Type (2016-2021)
Table 26. Global Psoriasis Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Psoriasis Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Psoriasis Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Psoriasis Drugs Revenue Market Share by Application (2016-2021)
Table 30. Global Psoriasis Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Psoriasis Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Psoriasis Drugs Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Psoriasis Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Psoriasis Drugs Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Psoriasis Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Psoriasis Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Psoriasis Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Psoriasis Drugs Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Psoriasis Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Psoriasis Drugs Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Psoriasis Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Psoriasis Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Psoriasis Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Psoriasis Drugs Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Psoriasis Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Psoriasis Drugs Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Psoriasis Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Psoriasis Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Psoriasis Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Psoriasis Drugs Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Psoriasis Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Psoriasis Drugs Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Psoriasis Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Psoriasis Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Psoriasis Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Psoriasis Drugs Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Psoriasis Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Psoriasis Drugs Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Psoriasis Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Psoriasis Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Psoriasis Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 62. AbbVie Company Details
Table 63. AbbVie Business Overview
Table 64. AbbVie Psoriasis Drugs Product
Table 65. AbbVie Revenue in Psoriasis Drugs Business (2016-2021) & (US$ Million)
Table 66. AbbVie Recent Development
Table 67. Amgen Company Details
Table 68. Amgen Business Overview
Table 69. Amgen Psoriasis Drugs Product
Table 70. Amgen Revenue in Psoriasis Drugs Business (2016-2021) & (US$ Million)
Table 71. Amgen Recent Development
Table 72. Johnson & Johnson Company Details
Table 73. Johnson & Johnson Business Overview
Table 74. Johnson & Johnson Psoriasis Drugs Product
Table 75. Johnson & Johnson Revenue in Psoriasis Drugs Business (2016-2021) & (US$ Million)
Table 76. Johnson & Johnson Recent Development
Table 77. Novartis Company Details
Table 78. Novartis Business Overview
Table 79. Novartis Psoriasis Drugs Product
Table 80. Novartis Revenue in Psoriasis Drugs Business (2016-2021) & (US$ Million)
Table 81. Novartis Recent Development
Table 82. Eli Lilly & Company Company Details
Table 83. Eli Lilly & Company Business Overview
Table 84. Eli Lilly & Company Psoriasis Drugs Product
Table 85. Eli Lilly & Company Revenue in Psoriasis Drugs Business (2016-2021) & (US$ Million)
Table 86. Eli Lilly & Company Recent Development
Table 87. AstraZeneca Company Details
Table 88. AstraZeneca Business Overview
Table 89. AstraZeneca Psoriasis Drugs Product
Table 90. AstraZeneca Revenue in Psoriasis Drugs Business (2016-2021) & (US$ Million)
Table 91. AstraZeneca Recent Development
Table 92. Celgene Corporation Company Details
Table 93. Celgene Corporation Business Overview
Table 94. Celgene Corporation Psoriasis Drugs Product
Table 95. Celgene Corporation Revenue in Psoriasis Drugs Business (2016-2021) & (US$ Million)
Table 96. Celgene Corporation Recent Development
Table 97. UCB Company Details
Table 98. UCB Business Overview
Table 99. UCB Revenue in Psoriasis Drugs Business (2016-2021) & (US$ Million)
Table 100. UCB Recent Development
Table 101. Merck Company Details
Table 102. Merck Business Overview
Table 103. Merck Psoriasis Drugs Product
Table 104. Merck Revenue in Psoriasis Drugs Business (2016-2021) & (US$ Million)
Table 105. Merck Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Psoriasis Drugs Market Share by Type: 2020 VS 2027
Figure 2. Tumor Necrosis Factor Inhibitor Features
Figure 3. Interleukin Inhibitors Features
Figure 4. Others Features
Figure 5. Global Psoriasis Drugs Market Share by Application: 2020 VS 2027
Figure 6. Topicals Case Studies
Figure 7. Systemic Case Studies
Figure 8. Biologics Case Studies
Figure 9. Psoriasis Drugs Report Years Considered
Figure 10. Global Psoriasis Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Psoriasis Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Psoriasis Drugs Market Share by Regions: 2020 VS 2027
Figure 13. Global Psoriasis Drugs Market Share by Regions (2022-2027)
Figure 14. Global Psoriasis Drugs Market Share by Players in 2020
Figure 15. Global Top Psoriasis Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Psoriasis Drugs as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Psoriasis Drugs Revenue in 2020
Figure 17. Global Psoriasis Drugs Revenue Market Share by Type (2016-2021)
Figure 18. Global Psoriasis Drugs Revenue Market Share by Type (2022-2027)
Figure 19. North America Psoriasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Psoriasis Drugs Market Share by Type (2016-2027)
Figure 21. North America Psoriasis Drugs Market Share by Application (2016-2027)
Figure 22. North America Psoriasis Drugs Market Share by Country (2016-2027)
Figure 23. United States Psoriasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Psoriasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Psoriasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Psoriasis Drugs Market Share by Type (2016-2027)
Figure 27. Europe Psoriasis Drugs Market Share by Application (2016-2027)
Figure 28. Europe Psoriasis Drugs Market Share by Country (2016-2027)
Figure 29. Germany Psoriasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Psoriasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Psoriasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Psoriasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Psoriasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Psoriasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Psoriasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Psoriasis Drugs Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Psoriasis Drugs Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Psoriasis Drugs Market Share by Region (2016-2027)
Figure 39. China Psoriasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Psoriasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Psoriasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Psoriasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Psoriasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Psoriasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Psoriasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Psoriasis Drugs Market Share by Type (2016-2027)
Figure 47. Latin America Psoriasis Drugs Market Share by Application (2016-2027)
Figure 48. Latin America Psoriasis Drugs Market Share by Country (2016-2027)
Figure 49. Mexico Psoriasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Psoriasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Psoriasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Psoriasis Drugs Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Psoriasis Drugs Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Psoriasis Drugs Market Share by Country (2016-2027)
Figure 55. Turkey Psoriasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Psoriasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Psoriasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. AbbVie Revenue Growth Rate in Psoriasis Drugs Business (2016-2021)
Figure 59. Amgen Revenue Growth Rate in Psoriasis Drugs Business (2016-2021)
Figure 60. Johnson & Johnson Revenue Growth Rate in Psoriasis Drugs Business (2016-2021)
Figure 61. Novartis Revenue Growth Rate in Psoriasis Drugs Business (2016-2021)
Figure 62. Eli Lilly & Company Revenue Growth Rate in Psoriasis Drugs Business (2016-2021)
Figure 63. AstraZeneca Revenue Growth Rate in Psoriasis Drugs Business (2016-2021)
Figure 64. Celgene Corporation Revenue Growth Rate in Psoriasis Drugs Business (2016-2021)
Figure 65. UCB Revenue Growth Rate in Psoriasis Drugs Business (2016-2021)
Figure 66. Merck Revenue Growth Rate in Psoriasis Drugs Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
  • Global Public and Personal Safety Industry Research Report, Growth Trends and Competitive Analysis 2023-2029
    Published: 11-Jan-2024        Price: US 5600 Onwards        Pages: 177
    The global Public and Personal Safety Industry market size was US$ 6,398.95 million in 2022 and is forecast to a readjusted size of US$ 18,265.36 million by 2029 with a CAGR of 16.88% during the forecast period 2023-2029. The global key companies of Public and Personal Safety Industry include Hexagon, Motorola Solutions Inc, NEC, Tyler Technologies Inc and Indra Sistemas, accounting for 24.50% market share in terms of revenues in 2022. The market research report offered here is a v......
  • Global Digital Watermark Technology Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global market for Digital Watermark Technology estimated was at US$ 111.3 million in the year 2022, is projected to reach a revised size of US$ 210.53 million by 2029, growing at a CAGR of 9.4% during the forecast period 2023-2029. North American market for Digital Watermark Technology was valued at $ 39.07 million in 2022 and will reach $ 68.79 million by 2029, at a CAGR of 8.2 % during the forecast period of 2023 through 2029. Asia-Pacific market for Digital Watermark Technol......
  • Global Location Based Marketing Services Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74
    The global Location Based Marketing Services market was valued at US$ 46700 million in 2023 and is anticipated to reach US$ 144870 million by 2030, witnessing a CAGR of 17.2% during The forecast period 2024-2030. North American market for Location Based Marketing Services is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Location Based Marketing Services is estima......
  • Global Auto Repair and Beauty Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 72
    The global Auto Repair and Beauty market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. Automotive is a key driver of this industry. According to data from The World Automobile Organization (OICA), global automobile production and sales in 2017 reached their peak in The past 10 years, at 97.3 million and 95.89 million respectively. In 2018, The global economic expansion ended, and The gl......
  • Global Viral Vector Development Service Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global Viral Vector Development Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Viral Vector Development Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Viral Vector Development Service is estimated to increase from......
  • Global Building Automation Systems (BAS) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Building Automation Systems (BAS) market was valued at US$ 75680 million in 2023 and is anticipated to reach US$ 143970 million by 2030, witnessing a CAGR of 9.5% during The forecast period 2024-2030. North American market for Building Automation Systems (BAS) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Building Automation Systems (BAS) is estimat......
  • Global SLAM in Mobile Robots and Smart AR Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 92
    This report studies The SLAM Robots market, Simultaneous localization and mapping, or SLAM for short, is The process of creating a map using a robot or unmanned vehicle that navigates that environment while using The map it generates. SLAM is technique behind robot mapping or robotic cartography. The robot or vehicle plots a course in an area, but at The same time, it also has to figure out where its own self is located in The place. The process of SLAM uses a complex array of computations, algo......
  • Global Digital Educational Publishing Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Digital Educational Publishing market was valued at US$ 8324.5 million in 2023 and is anticipated to reach US$ 14580 million by 2030, witnessing a CAGR of 7.9% during The forecast period 2024-2030. North American market for Digital Educational Publishing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Digital Educational Publishing is estimated to inc......
  • Global Human Source Service Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70
    The global Human Source Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Human Source Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Human Source Service is estimated to increase from $ million in 2023 to reach $ millio......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs